January 8, 2024 | Client News
Statistically significant drug effects were observed in FDA-recognized efficacy endpoints as early as the 15-day first visit after dosing Statistically significant improvement was observed in both a “sign” (total conjunctival staining) and two “symptoms” (burning/stinging and blurred vision), endpoints of Dry Eye Disease A clear and informed path now established for further development of drug […]
January 5, 2024 | Client News
DETROIT, Jan. 04, 2024 (GLOBE NEWSWIRE) — Amesite Inc. (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets, announces the launch of a new asynchronous Implicit Bias course tailored for healthcare professionals. This course is the result of a partnership between Amesite and CMU’s College of Medicine, along […]
January 5, 2024 | Client News
Oilfield Fully-Permitted to Restart Production from Six Previously Producing Wells San Ardo Water Disposal Well WD-1 Successfully Refurbished and the Testing and Repairs of On-Site Facilities In-Progress Bakersfield, CA, Jan. 04, 2024 (GLOBE NEWSWIRE) — Trio Petroleum Corp (NYSE American: TPET) (“Trio” or the “Company”), a California-based oil and gas company, today provided an update […]
January 5, 2024 | Client News
Estimated Contingent Resources of 42-92 Million Barrels of Oil Development of this Potential Giant Oilfield Commencing January 2024 Bakersfield, CA, Jan. 05, 2024 (GLOBE NEWSWIRE) — Trio Petroleum Corp (NYSE American: TPET) (“Trio” or the “Company”), a California-based oil and gas company, today announced that it has secured an option (the “Option”) to acquire a 20% interest […]
January 5, 2024 | Client News
NEW YORK, Jan. 05, 2024 (GLOBE NEWSWIRE) — Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies, today announced filing of a new patent application relating to composition and methods for combining GLP-1ra and foralumab, a fully human anti-CD3 antibody, to achieve further reductions in systemic and vascular inflammation […]
January 5, 2024 | Client News
Phoenix, Arizona—(Newsfile Corp. – January 5, 2024) – SinglePoint Inc. (CBOE: SING) (“SinglePoint” or “the Company”), a provider of renewable energy, energy supply, and healthy building solutions, provides an update highlighting 2023 accomplishments and its plans to increase shareholder value in 2024. After successfully listing on the CBOE BZX Exchange in December, SinglePoint enters the […]
January 4, 2024 | Client News
SHELTON, CT / ACCESSWIRE / January 4, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a leader in the development of highly effective antiviral therapies based on a novel nanomedicines technology, announced today that it is presenting at Biotech Showcase™ 2024. Event Information: Event NanoViricides Presentation at the Biotech Showcase, San Fransisco Day & Date Tuesday, January 9, […]
January 4, 2024 | Client News
The collaboration included six different provisional patent applications filed by Clearmind with the United States Patent and Trademark Office in February 2023 to protect the novel combinations of psychedelics with SciSparc’s PEA TEL AVIV, Israel, Jan. 04, 2024 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on […]
January 4, 2024 | Client News
Chairman of the Board Heng Fai Ambrose Chan Adds 672,173 Shares to Increase Investment in Company NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) — DSS, Inc. (NYSE American: DSS, “Company”), a multinational company operating across four distinct market sectors, announced today a significant investment by its Chairman of the Board, Heng Fai Ambrose Chan. In a […]